Adit Ben-Baruch

Medicine & Life Sciences

1. Chemokines 100%
2. Breast Neoplasms 84%
3. Neoplasms 56%
4. Interleukin-8 49%
5. Chemokine Receptors 42%
6. Tumor Microenvironment 41%
7. Chemokine CCL5 37%
8. CXC Chemokines 32%
9. Interleukin-8 Receptors 29%
10. CC Chemokines 26%
11. Triple Negative Breast Neoplasms 24%
12. Chemokine CXCL6 24%
13. Phosphorylation 23%
14. Neoplasm Metastasis 22%
15. Leukocytes 21%
16. Tumor Necrosis Factor-alpha 21%
17. Cytokines 21%
18. Inflammation 20%
19. Mesenchymal Stem Cells 20%
20. Interleukin-1 20%
21. Cell Movement 19%
22. Breast 19%
23. Recycling 19%
24. Cancer-Associated Fibroblasts 19%
25. Interleukin-8A Receptors 19%
26. Focal Adhesion Protein-Tyrosine Kinases 18%
27. T-Lymphocytes 16%
28. Ligands 16%
29. Neuroblastoma 16%
30. Interleukin-8B Receptors 16%
31. Chemokine CCL2 15%
32. Chemotaxis 15%
33. Phenotype 14%
34. Epithelial-Mesenchymal Transition 13%
35. Job Syndrome 12%
36. Neutrophils 11%
37. Estrogens 11%
38. Receptors, Tumor Necrosis Factor, Type II 11%
39. Actin Cytoskeleton 11%
40. Polyomavirus 10%
41. Adenocarcinoma 10%
42. Monocytes 10%
43. Macrophage Inflammatory Proteins 10%
44. Integrins 9%
45. CXCR3 Receptors 9%
46. Chemokine CCL7 9%
47. human CXCL6 protein 9%
48. Epidermal Growth Factor 8%
49. Neoplastic Stem Cells 8%
50. Opiate Alkaloids 8%